Duration of disease, neuropathic symptoms, and plantar sensitivity in patients with diabetes with and without previous plantar ulceration

Wounds

Volumn 20, Issue 2, 2008, Pages 37-45

  Bacarin, Tatiana De Almeida ^a   Akashi, Paula M H ^a   Sacco, Isabel De C N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41649098440     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Boulton AJ. The diabetic foot. Med Clin North Am. 1 988;72 (6): 1513-1530.
2. Masson EA, Hay EM, Stockley I, et al.Abnormal foot pressures alone may not cause ulcetarion. Diabetes Med. 1989;6:426-428.
3. Sosenko JM, Kato M, Soto R, Bild DE.Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care. 1990;13(10):1057-1601.
4. Reiber EG,Vileikyte L,Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157-162.
5. Perry JE, Hall JO,Davis BL. Simultaneous measurement of plantar pressure and shear forces in diabetic individuals. Gait Posture. 2002; 15(1): 101-107.
6. Raskin P. Risk factors for the development of diabetic complications. J Diabetes Complications. 1994; 8(4): 195-200.
7. Brill LR, Cavanagh PR, Gibbons GW, Levin ME. Prevention of lower extremity amputation in patients with diabetes. Treatment of Chronic Wounds. Curative Health Services; 1996: No.7.Available at: http://www2.curative.com/ CUEBIC/ CURATIVE/localdata/ Mono7.pdf.Accessed:April 25, 2005.
8. Cavanagh PR, Simoneau GG, Ulbrecht JS. Ulceration, unsteadiness, and uncertainty: the biomechanical consequences of diabetes mellitus. J Biomech. 1993;26 (Suppl 1):23-40.
9. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27(6):1458-1486.
10. Rio Total. No Brasil, o diabetes é a quarta causa básica de morte e a primeira de cegueira e de amputações de membros inferiores. Rio de Janeiro, Brazil. Rio Total; 1996. Accessed: August 13, 2006. Vida Saudável. Available at: http://www.riototal.com.br/sa-de/saude027. htm.
11. Rich J,Veves A. Forefoot and rearfoot plantar pressures in diabetic patients: correlation to foot ulceration. WOUNDS. 2000;12(4):82-87.
12. Frykberg RG. Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998; 21 (10) : 1714-1719.
13. International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot. The Netherlands; Miro International Pty Ltd; 1999.
14. Cavanagh PR. Sims DS Jr, Sanders LJ. Body mass is a poor predictor of peak plantar pressure in diabetic men. Diabetes Care. 1991 ; 14 (8):750-755.
15. Carrington AL, Shaw JE,Van Schie CH,Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over 6-year outcome period? Diabetes Care. 2002; 25 (11):2010-2015.
16. Taylor AJ, Menz HB,Keenan AM.Effects of experimentally induced plantar insensitivity on forces and pressures under the foot during normal walking. Gait Posture. 2004;20(3):232-237.
17. Nurse MA, Nigg BM.The effect of changes in foot sensation on plantar pressure and muscle activity. Clin Biomech (Bristol,Avon). 2001;16(9):719-727.
18. Michigan Neuropathy Screening Instrument. MichiganDiabetes Research and Training Center. Accessed: April 25, 2005. Available at: http:// www.med.umich.edu/mdrtc/profs/survey.html* mnsi.
19. Armstrong DG, Lavery LA. Elevated peak plantar pressure in patients who have Charcot arthropathy. J Bone Joint Surg Am. 1998;80(3):365-369.
20. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA.A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994; 17(11):1281-1289.
21. Leonard DR, Farooqi MH, Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment. Diabetes Care. 2004;27(1):168-172.
22. Kästenbauer T, Irsigler P, Sauseng S, Grimm A, Prager R. The prevalence of symptoms of sensorimotor and autonomic neuropathy in type 1 and type 2 diabetic subjects. J Diabetes Complications. 2004:18(1):27-31.
23. Rosenberg ME, Tervo TM, lmmonen IJ, Müller LJ, Grönhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 2000;41 (10):2915-2921.
24. Hanley AJG, Harris SB, Mamakeesick M, et al. Complications of type 2 diabetes among aboriginal Canadians: increasing the understanding of prevalence and risk factors. Can J Diabetes. 2003;27(4):455-463.
25. Sacco IC, Amadio AC.A study of biomechanics parameters in gait analysis and somatic sensorial thresholds of diabetic neuropathic patients. Clin Biomech. 2000; 15(3): 196-202.
26. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 2nd ed. Philadelphia, Pa: FA Davis; 1989.
27. Sacco ICN. Estudo de parâmetros biomecânicos na marcha e limares somatosensorials em pacientes portadores de neuropatia diabética [dissertation]. São Paulo, Brazil: School of Physical Education and Sport, University of São Paulo, Brazil; 1997.
28. Bischof F, Meyerhoff C, Türk K. Der Diabetische Fuß. Geislingen, Germany: C. Maurer-Verlag; 1996.
29. Mueller MJ.Application of plantar pressure assessment in footwear and insert design. J Orthop Sports Phys Ther. 1999;29(12):747-755.
30. Chkhartishvili D, Khachapuridze N, Natriashivili G, et al. Nerve conduction abnormalities in children with type I diabetes. Ann Biomed Res Ed. 2002;2(4):331-334.
31. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet. 1997;350(Suppl 1):S19-S13.
32. Dias RJS, Carneiro AP. Neuropatia diabética: fisiopatologia, clínica e eletroneuromiografia. Acta Fisiátrica. 2000;7(1):35-44.
33. Pham H, Armstrong DG. Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care. 2000;23(5):606-611.
34. American Diabetes Association. Consensus Statement: Standardized Measures in Diabetic Neuropathy. Diabetes Care. 1996;19(Suppl 1):S72-S92.
35. Dyck PJ, Karnes J, O' Brien PC. Diagnosis, staging, and classification of diabetic neuropathy and associations with other complications. In: Dyck PJ.Thomas PK,Asbury A, et al, eds. Diabetic Neuropathy. Philadelphia, Pa:WB Saunders; 1987.
36. Dyck PJ, Zimmerman BR, Vilen TH, et al. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med. 1988;319(9):542-548.
37. Bradley WG, Daroff RB. Fenichel GM, Marsden CD. Neurology in Clinical Practice. 3rd ed. Boston, Mass: Butterworth-Heinemann; 2000.
38. Moghtaderi A, Bakhshipour A. Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108 (5):477-481.
39. Lunetta M, Le Moli R, Grasso G, Sangiorgio L.A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract. 1998:39(3):165-172.